Table 2.
Variable | Univariate analysis | ||
---|---|---|---|
HR | 95% CI | P value | |
Univariate analyses | |||
Age(<50 vs ≥50) | 1.989 | 0.633–6.252 | 0.239 |
FIGO stage (I and II vs III and IV) | 2.303 | 0.819–6.471 | 0.114 |
Tumour sizes ≥3 vs <3 | 2.835 | 0.968–8.304 | 0.057 |
LN status (positive vs negative) | 0.54 | 0.184–1.581 | 0.261 |
Histological grade (low differentiation vs moderate and high differentiation) | 0.36 | 0.143–0.908 | 0.031* |
Vaginal recurrence or metastasis (present vs absent) | 33.266 | 4.313–256.574 | 0.001* |
GAS5 expression (high vs low) | 4.755 | 1.340–16.875 | 0.016* |
Multivariate analyses | |||
Vaginal recurrence or metastasis (present vs absent) | 34.481 | 4.438–267.891 | 0.001 |
Histological grade (low differentiation vs moderate and high differentiation) | 0.287 | 0.101–0.816 | 0.019 |
GAS5 expression (high vs low) | 0.175 |
HR hazard ratio, CI confidence interval.
*P < 0.05.